quantisnow
FeedTopReportsPricing
⌘K
Live feed
11:01:04·1487d
FDARegulatory
Zogenix Inc. logo

FDA Approval for FINTEPLA issued to ZOGENIX INC

ZGNX· Zogenix Inc.
Health Care
Original source

Companies

  • ZGNX
    Zogenix Inc.
    Health Care

Recent analyst ratings

  • Feb 28UpdateNorthland Capital-
  • Jan 19UpdateNeedham-
  • Dec 20UpdateSVB Leerink$32.00
  • Sep 9UpdateUBS$23.00
  • Aug 6UpdateNeedham$44.00
  • Aug 6UpdateSVB Leerink$37.00

Related

  • PR106d
    ReAlta Life Sciences Announces Appointment of Jonathan Rigby to Board of Directors
  • FDA1058d
    FDA Approval for FINTEPLA issued to ZOGENIX INC
  • FDA1205d
    FDA Approval for FINTEPLA issued to ZOGENIX INC
  • FDA1408d
    FDA Approval for FINTEPLA issued to ZOGENIX INC
  • FDA1487d
    FDA Approval for FINTEPLA issued to ZOGENIX INC
  • FDA1487d
    FDA Approval for FINTEPLA issued to ZOGENIX INC
  • NEWS1490d
    The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO
  • NEWS1495d
    Benzinga Pro's Top 5 Stocks To Watch For Monday, Mar. 21, 2022: BA, COIN, NILE, ZGNX, MULN
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022